Forschungsprojekte
Ergebnisse pro Seite:
10
2017 - 2019
AFM11 in patients with relapsed and/or refractory CD19 positive B-cell NHL (#667)- Univ.-Prof. Dr. Georg Heß
2017 - 2019
Impact of mutational pathways on immune environment, neoantigens and tumor rejection for the development of comprehensive biomarker panels in cancer immunotherapy- Prof. Dr. Angela Krackhardt,
- Prof. Dr. Stefan Fröhling,
- Prof. Dr. Wilko Weichert,
- Prof. Dr. Hanno Glimm,
- Prof. Dr. Benedikt Brors,
- Prof. Dr. Peter Schirmacher,
- Dr. Felix Lasitschka,
- Dr. Albrecht Stenziger,
- Prof. Dr. Roland Rad,
- Prof. Dr. Karsten Spiekermann,
- Prof. Dr. Marion Subklewe,
- Prof. Dr. Christian Brandts,
- PD Dr. Thomas Kindler,
- Prof. Dr. Florian Greten,
- Univ.-Prof. Dr. Thomas Wölfel,
- Univ.-Prof. Dr. Matthias Theobald,
- Dr. Hakim Echchannaoui,
- Prof. Dr. Sebastian Bauer,
- Jens Siveke,
- Prof. Dr. Nikolas von Bubnoff,
- Dr. Melanie Börries,
- Prof. Dr. Silke Lassmann,
- Dr. Stefan Haug,
- Prof. Dr. Martin Werner,
- PD Dr. Gunnar Folprecht,
- Prof. Dr. Evelin Schrock,
- Dr. Barbara Klink,
- PD Dr. Anne Letsch,
- PD Dr. Sebastian Ochsenreither,
- PD Dr. Frederick Klauschen,
- Prof. Dr. Matthias Mann,
- Prof. Dr. Jürgen Cox
2017 - 2019
Chimeric antigen receptor-engineered natural killer cells as a universal cellular therapeutic for adoptive cancer immunotherapy (collaborative research project within translational immunotherapy program)- Prof. Dr. Winfried Wels,
- Univ.-Prof. Dr. Matthias Theobald,
- Prof. Dr. Michael Bachmann,
- Prof. Dr. Achim Temme,
- Prof. Dr. Torsten Tonn,
- Prof. Dr. Dirk Jäger,
- PD Dr. Jessica Hassel,
- Prof. Dr. Jürgen Becker,
- PD Dr. Annette Paschen
2017 - 2025
Junior Group of the German Cancer Consortium (DKTK)- Dr. Borhane Guezguez,
- Univ.-Prof. Dr. Matthias Theobald